An investigation of the range of cognitive impairments induced by scopolamine 0·6 mg s.c
Tóm tắt
The present study was conducted to determine the degree to which impairments in attention accompany the memory deficits produced by scopolamine. Eighteen healthy young volunteers received scopolamine 0·6 mg subcutaneously on three experimental sessions and placebo on three others. On each session, prior to, and 60 min after injection, the subjects underwent an automated computerized battery of 11 cognitive tasks. The study was run double‐blind and the order of treatment conditions over successive visits was counterbalanced between subjects. Scopolamine produced marked and significant decrements on all major aspects of performance from the battery. The drug lowered the efficiency of the detection and processing of information in tests of visual vigilance, rapid information processing, choice reaction, letter cancellation and logical reasoning. These effects were accompanied by a lowering of critical flicker‐fusion frequency and subjective alertness. Memory was also impaired on tests of immediate recall, delayed recall, recognition and memory scanning. These findings confirm and extend previous work, demonstrating that scopolamine impairs the selection and evaluation of environmental information, as well as reducing the likelihood of information being subsequently recalled or recognized. Whether the former effects contribute to the latter is not known, but this must be considered a possibility. This potential role of processing deficits in memory loss associated with cholinergic blockade is briefly considered in relation to the cholinergic hypothesis of geriatric memory loss.
Từ khóa
Tài liệu tham khảo
Bartus R. T., 1986, Treatment development strategies for Alzheimer's disease, 421
Bond A., 1974, The use of analogue scales in rating subjective feelings, British Journal of Medical Psychology, 80, 1
Brickenkamp R., 1981, Test d2 Aufmerksamkeits‐Belastungs‐Test Handanweisung
Colquhoun W. P., 1962, Effects of hyoscine and meclozine on vigilance and short‐term memory, British Journal of Industrial Medicine, 19, 287
Crow T. J., 1982, Psychoapharmacology of Old Age, 24
Grubbs F. E., 1972, Extension of sample sizes and percentage points for significance tests of outlying observations, Technometrics, 17, 473
Hrbek J., 1970, Effect of physostigmine on the inhibitory action of scopolamine in man, Activita Nervosa Superior, 12, 273
Hrbek J., 1971, Effect of physostigmine on the inhibitory action of scopolamine in man, Activita Nervosa Superior, 13, 199
Keppel G., 1982, Design and Analysis: A Researcher's Handbook
Kirk R. E., 1968, Experimental Design: Procedures for the behavioural sciences
Ostfeld A. M., 1962, Central nervous system effects of hyoscine in man, Journal of Pharmacology and Therapeutics, 137, 133
Rogers H., 1984, Aids to Clinical Pharmacology and Therapeutics
Safer D. J., 1971, The central effects of scopolamine in man, Biological Psychiatry, 3, 347
Smith J. M., 1976, Critical flicker fusion (CFF) and psychoactive drugs in normal subjects – a review, Psychopharmacology, 69, 209
Thorndike E. L., 1944, The Teacher's Word Book of 30,000 Words
Tietjen G. L., 1972, Some Grubbs‐type statistics for the detection of several outliers, Technometrics, 14, 583, 10.1080/00401706.1972.10488948
Wesnes K.(1985).A fully automated psychometric test battery for human psychopharmacology. Abstracts of IVth World Congress of Biological Psychiatry Philadelphia September p.153.
Wesnes K., 1987, Human Psychopharmacology: Measures and Methods, 79